ÂÜÀòÂÒÂ×

Amy Tibbo is a Business Support Scientist at Bionano Genomics, Inc. since March 2022, focusing on clinical and scientific projects across the UK, Ireland, and Germany, while enhancing the utilization of OGM in various research settings. Previously, Amy worked as a Postdoctoral Researcher at the Cancer Research UK Beatson Institute from March 2020 to April 2022, investigating therapeutic targets in metastatic prostate cancer. At the University of Glasgow, Amy served as the Academic Lead on the Access Biology Course and as a Graduate Teaching Assistant, leading laboratory classes and developing new undergraduate courses. Amy holds a PhD in Biochemistry from the University of Glasgow, completed in 2020, and a BSc (Hons) in Genetics obtained in 2016.